Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2018, Vol. 45 Issue (5): 671-676    DOI: 10.12891/ceog4341.2018
Original Research Previous articles | Next articles
Association between metabolic risks and bone mineral density in postmenopausal women
Jung Yeob Seoung1, Suk Woo Lee1, Young Mo Kang1, Min Jung Kim1, Jae Min Park1, Hye Min Moon2, Chae Chun Rhim1, *()
1 Department of Obstetrics and Gynecology, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea
2 Department of Obstetrics and Gynecology, College of Medicine, The Catholic University of Korea, Korea
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  
Background: Menopause is associated with osteoporosis and an increased risk of metabolic disorders, including obesity, abdominal adiposity, hyperlipidemia, hypertension, and insulin resistance, which may increase the risk of cardiovascular disease (CVD). Recent studies have demonstrated a correlation between fat, glucose, and bone metabolism which could contribute to CVD and osteoporosis. This study examined the association between metabolic risk factors and bone mineral density (BMD) in postmenopausal women. Materials and Methods: The authors determined the anthropometric values [waist-hip ratio (WHR), visceral fat area (VFA), body fat mass (BFM), and skeletal muscle mass (SMM)], lipid profile, fasting plasma glucose levels, high-sensitivity C-reactive protein levels, homeostasis model assessment of insulin resistance (HOMA-IR) scores, serum leptin and adiponectin levels, serum osteocalcin level [total osteocalcin (tOC) and undercarboxylated osteocalcin (ucOC)], and BMDs of the lumbar spine and femoral neck in 137 postmenopausal women. Results: There was a positive correlation between BFM, HOMA-IR score, serum leptin level, and BMD of the lumbar spine, and a negative correlation between BFM, total cholesterol, serum adiponectin, and BMD of the lumbar spine after adjusting for age, years since menopause, current alcohol consumption, and current smoking status. In a multiple regression analysis, serum adiponectin level and SMM were the most important predictors of the BMD of the lumbar spine. Conclusion: There were several metabolic risk variables that had a harmful effect on the BMD of the lumbar spine, but not the femoral neck. However, higher serum adiponectin levels were negatively correlated with BMD of the lumbar spine as adiposity decreased.
Key words:  Adipokine      Bone mineral density      Metabolic syndrome      Osteocalcin      Postmenopause     
Published:  10 October 2018     
*Corresponding Author(s):  CHAE CHUN RHIM     E-mail:  ccrhim@hallym.or.kr

Cite this article: 

Jung Yeob Seoung, Suk Woo Lee, Young Mo Kang, Min Jung Kim, Jae Min Park, Hye Min Moon, Chae Chun Rhim. Association between metabolic risks and bone mineral density in postmenopausal women. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(5): 671-676.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog4341.2018     OR     https://ceog.imrpress.com/EN/Y2018/V45/I5/671

[1] R. Tachibana, H. Matsushita, A. Minami, N. Morita, S. Shimizu, H. Kanazawa, T. Suzuki, K. Watanabe, A. Wakatsuki. Dietary sesame diminishes bone mass and bone formation indices in ovariectomized rats[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 546-551.
[2] F. N. Tuysuzoglu, G. A. Ilhan, B. Yildizhan. The impact of surgical menopause on metabolic syndrome, bone mineral density, and vasomotor symptoms[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 179-182.
[3] N. Morita, H. Matsushita, A. Minami, S. Shimizu, R. Tachibana, H. Kanazawa, T. Suzuki, K. Watanabe, A. Wakatsuki. Effect of the methanol extract of the Lion's Mane mushroom, Hericium erinaceus, on bone metabolism in ovariectomized rats[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 47-52.
[4] H.M.G. Youssef, E.S. Marei, L.A. Rashed. Long non-coding RNA steroid receptor activator in polycystic ovary syndrome: possible association with metabolic syndrome[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 757-762.
[5] M. Trisovic, O. Mladenovic, J. Bila, K. Lalić, D. Kisic Tepavcevic. The predictive value of metabolic syndrome in the evaluation of pregnancy course and outcome[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 776-778.
[6] H.A. Mansouri. Do bone turnover markers change with a steep drop in maternal steroids?[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 784-786.
[7] Lingping Zhu, Xing Chen, Wenpei Bai, Xiaoyan Yan. Factors associated with the quality of life in women with perimenopausal and postmenopausal status: a cross-sectional questionnaire survey from China[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(1): 90-103.
[8] Y.J. Lee, K.Y. Yun, S.C. Kim, J.K. Joo, K.S. Lee. The association between cystatin C and metabolic syndrome according to menopausal status in healthy Korean women[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(5): 716-720.
No Suggested Reading articles found!